Notable differentially edited genes include RHOA, which is active in cell migration and is associated with metastasis in multiple cancer types [42–44], and ARL16, a reported negative regulator of RIG-I activity [45], consistent with the observed enrichment of immune-relevant genes that were differentially edited in bulk tumors. This evidence concerns the gene RIGI and cancer.